ERBB3 and neoplasm: Even though the choice of chelator did not affect the tumor uptake, the results of the current study suggest that the radiometal-chelator complex greatly influences the uptake in organs with endogenous expression of HER3, particularly in liver, both in initial uptake (4 h pi) and retention (24 h pi).